Stable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imaging

Nanomedicine

Volumn 9, Issue 16, 2014, Pages 2499-2509

  Cisneros, Brandon T ^a,b   Law, Justin J ^a   Matson, Michael L ^a   Azhdarinia, Ali ^c   Sevick Muraca, Eva M ^c   Wilson, Lon J ^a  

^a RICE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

carbon nanotube; contrast agent; MRI; multimodal imaging; positron emission tomography

Indexed keywords

COPPER 64; GADOLINIUM; PHOSPHATE BUFFERED SALINE; SINGLE WALLED NANOTUBE; CARBON NANOTUBE; CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CHELATION; CIRCULATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG SYNTHESIS; ECHOGRAPHY; ENCAPSULATION; FEMALE; IMAGE ANALYSIS; IN VIVO STUDY; LUNG; MOLECULAR STABILITY; MOUSE; MULTIMODAL IMAGING; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SCANNER; NUDE MOUSE; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; TISSUE DISTRIBUTION; ANIMAL; CHEMISTRY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES;

ANIMALS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MULTIMODAL IMAGING; NANOTUBES, CARBON; POSITRON-EMISSION TOMOGRAPHY;

EID: 84918492891     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.26     Document Type: Article

References (38)

1. Hahn MA, Singh AK, Sharma P, Brown SC, Moudgil BM. Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives. Anal. Bioanal. Chem. 399(1), 3-27 (2011).
2. Lee DE, Koo H, Sun IC, Ryu JH, Kim K, Kwon IC. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem. Soc. Rev. 41(7), 2656 (2012).
3. Sailor MJ, Park JH. Hybrid nanoparticles for detection and treatment of cancer. Adv. Mater. 24(28), 3779-3802 (2012).
4. Treacy MMJ, Ebbesen TW, Gibson JM. Exceptionally high Young's modulus observed for individual carbon nanotubes. Nature 381(6584), 678-680 (1996).
5. Ouyang M, Huang JL, Lieber CM. Fundamental electronic properties and applications of single-walled carbon nanotubes. Acc. Chem. Res. 35(12), 1018-1025 (2002).
6. Pantarotto D, Briand JP, Prato M, Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun. 1, 16-17 (2004).
7. Guven A, Rusakova IA, Lewis MT, Wilson LJ. Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery. Biomaterials 33(5), 1455-1461 (2012).
8. Gautam UK, Costa PMFJ, Bando Y et al. Recent developments in inorganically flled carbon nanotubes: successes and challenges. Sci. Technol. Adv. Mater. 11, 054501 (2010).
9. Hao D, Ai T, Goerner F, Hu X, Runge VM, Tweedle M. MRI contrast agents: basic chemistry and safety. J. Magn. Reson. Imaging 36(5), 1060-1071 (2012).
10. Hirsch A. Functionalization of single-walled carbon nanotubes. Angew. Chem. Int. Ed. 41(11), 1853-1859 (2002).
11. Mackeyev Y, Hartman KB, Ananta JS, Lee AV, Wilson LJ. Catalytic synthesis of amino acid and peptide derivatized gadonanotubes. J. Am. Chem. Soc. 131(24), 8342-8343 (2009).
12. Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun. 5, 571-577 (2005).
13. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv. Rev. 65(1), 36-48 (2013).
14. Liu Z, Yang K, Lee ST. Single-walled carbon nanotubes in biomedical imaging. J. Mater. Chem. 21(3), 586 (2011).
15. McDevitt MR, Chattopadhyay D, Jaggi JS et al. PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice. PLoS ONE 2(9), e907 (2007).
16. Liu Z, Cai W, He L et al. In vivo biodistribution and highly effcient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2(1), 47-52 (2007).
17. 124I labeled Gd3N@C80. Appl. Sci. 2(4), 465-478 (2012).
18. 3+ chelates: toward powerful T-1 and T-2 MRI contrast agents. Nano Lett. 8(1), 232-236 (2008).
19. Choi JH, Nguyen FT, Barone PW et al. Multimodal biomedical imaging with asymmetric single-walled carbon nanotube/iron oxide nanoparticle complexes. Nano Lett. 7(4), 861-867 (2007).
20. Hong SY, Tobias G, Al-Jamal KT et al. Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nat. Mater. 9(6), 485-490 (2010).
21. Sitharaman B, Kissell KR, Hartman KB et al. Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem. Commun. 31, 3915-3917 (2005).
22. Laurent S, Elst LV, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol. Imaging 1(3), 128-137 (2006).
23. Judenhofer MS, Wehrl HF, Newport DF et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat. Med. 14(4), 459-465 (2008).
24. 64Cu-labeled magnetic nanoparticles for multimodal imaging. Bioconjug. Chem. 19(7), 1496-1504 (2008).
25. Comes Franchini M, Pucci A, Locatelli E et al. Biocompatible nanocomposite for PET/MRI hybrid imaging. Int. J. Nanomedicine 7, 6021-6033 (2012).
26. Gu Z, Peng H, Hauge RH, Smalley RE, Margrave JL. Cutting single-wall carbon nanotubes through fuorination. Nano Lett. 2(9), 1009-1013 (2002).
27. Ashcroft JM, Hartman KB, Mackeyev Y et al. Functionalization of individual ultra-short single-walled carbon nanotubes. Nanotechnology 17(20), 5033-5037 (2006).
28. Sampath L, Kwon S, Hall MA, Price RE, Sevick-Muraca EM. Detection of cancer metastases with a dual-labeled near-infrared/positron emission tomography imaging agent. Transl. Oncol. 3(5), 307-317 (2010).
29. Ghosh SC, Ghosh P, Wilganowski N et al. Multimodal chelation platform for near-infrared fuorescence/nuclear imaging. J. Med. Chem. 56(2), 406-416 (2013).
30. Idée J-M, Port M, Raynal I, Schaefer M, Le Greneur S, Corot C. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam. Clin. Pharmacol. 20(6), 563-576 (2006).
31. Tran LA, Krishnamurthy R, Muthupillai R et al. Gadonanotubes as magnetic nanolabels for stem cell detection. Biomaterials 31(36), 9482-9491 (2010).
32. Kolosnjaj-Tabi J, Hartman KB, Boudjemaa S et al. In vivo behavior of large doses of ultrashort and full-length single-walled carbon nanotubes after oral and intraperitoneal administration to Swiss mice. ACS Nano. 4(3), 1481-1492 (2012).
33. Hartman KB, Laus S, Bolskar RD et al. Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging. Nano Lett. 8(2), 415-419 (2012).
34. Wang R, Carducci MD, Zheng Z. Direct hydrolytic route to molecular oxo-hydroxo lanthanide clusters. Inorg. Chem. 39(9), 1836-1837 (2000).
35. Sethi R, Mackeyev Y, Wilson LJ. The gadonanotubes revisited: a new frontier in MRI contrast agent design. Inorganica Chim. Acta. 393, 165-172 (2012).
36. Gizzatov A, Dimiev A, Mackeyev Y, Tour JM, Wilson LJ. Highly water soluble multi-layer graphene nanoribbons and related honey-comb carbon nanostructures. Chem. Commun. 48(45), 5602-5604 (2012).
37. Rogers BE, Anderson CJ, Connett JM et al. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. Bioconjug. Chem. 7(4), 511-522 (1996).
38. Salvador-Morales C, Townsend P, Flahaut E et al. Binding of pulmonary surfactant proteins to carbon nanotubes; potential for damage to lung immune defense mechanisms. Carbon 45(3), 607-617 (2007).